Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter ...

Capital Investment Advisors LLC lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.4% during the fourth quarter, according to its most recent disclosure with the ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative products and technologies for structural heart disease and critical care ...

IRVINE, Calif., January 07, 2025--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025. Evercore ISI ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against the other stocks that Jim Cramer has recently discussed. Jim Cramer, host of Mad ...

Evercore ISI raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $69 and keeps an In Line rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science ...

View Edwards Lifesciences Corporation (EW) current and estimated P/E ratio data provided by Seeking Alpha.